PATENT CLAIM ANALYSIS

Application Number: 16400514
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["514", "635000"]

Abstract:
The present invention relates to a pharmaceutical composition for inhibiting growth of cancer stem cells, containing an aldehyde inhibitor and a biguanide-based compound. The pharmaceutical composition according to the present invention contains a combination of an aldehyde inhibitor and a biguanide-based compound, which can effectively inhibit the growth of cancer stem cells such as neurospheres and can also inhibit the proliferation, invasion and metastasis of cancer cells, thereby preventing and/or treating cancer such as brain cancer.

Claim (Index 12):
The method of  claim 11 , wherein the gossypol and phenformin are contained at a weight ratio of 1:1 to 100.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 100.0
- Lexical Diversity: 1.86364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13089217', '15533842', '15121838', '15040002', '12994960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.761009523889072
- 35 USC 102 Novelty (BERT): 0.4959294196515411
- Combined Prediction Score: 0.7345015134653189
- Mean Citation Score: 202.067932
- Max Citation Score: 210.94104
- Similarity Product: 145.1159235204077

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test